Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Causes and Control

• Publication date

  2014-03-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10552-014-0369-3PMID 24664287PMCID PMC4028628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.

  2013cited by this paper
• Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

  2013cited by this paper
• Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study

  2013cited by this paper
• Effect of Elevated Basal Insulin on Cancer Incidence and Mortality in Cancer Incident Patients

  2012cited by this paper
• Association Between Plasma Leptin Levels and Diabetes Mellitus

  2011cited by this paper
• Finasteride Modifies the Relation between Serum C-Peptide and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

  2010cited by this paper
• A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival.

  2010cited by this paper
• Association between C-Peptide Concentration and Prostate Cancer Incidence in the CLUE II Cohort Study

  2010cited by this paper
• A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer.

  2010cited by this paper
• Risk factors for prostate cancer

  2009cited by this paper
• Association between plasma cholesterol and prostate cancer in the PSA era

  2008cited by this paper
• Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.

  2008cited by this paper
• Prediagnostic C-Peptide and Risk of Prostate Cancer

  2007cited by this paper
• Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study

  2007influential reference
• Insulin resistance is inversely related to prostate cancer: A prospective study in Northern Sweden

  2007cited by this paper
• Lifestyle and Dietary Correlates of Plasma Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1), Leptin, and C-Peptide: The Multiethnic Cohort

  2007cited by this paper
• Obesity, Adipokines, and Prostate Cancer in a Prospective Population-Based Study

  2006cited by this paper
• Are Findings from Studies of Obesity and Prostate Cancer Really in Conflict?

  2006cited by this paper
• The metabolic syndrome is associated with reduced risk of prostate cancer.

  2006cited by this paper
• Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

  2006cited by this paper
• A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer

  2006cited by this paper
• Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions.

  2005cited by this paper
• Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.

  2005cited by this paper
• Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era

  2005cited by this paper
• Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

  2005influential reference
• Cancer Causes & Control

  2004cited by this paper
• Risk Factors for Prostate Cancer

  2004cited by this paper
• Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging.

  2004cited by this paper
• Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.

  2004cited by this paper
• Insulin resistance and prostate cancer risk.

  2003cited by this paper
• Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls

  2003cited by this paper
• Plasma leptin is not associated with prostate cancer risk.

  2003cited by this paper
• Analysis of paradoxical observations on the association between leptin and insulin resistance

  2002cited by this paper
• Prostate cancer risk and serum levels of insulin and leptin: a population-based study.

  2001cited by this paper
• Energy balance and cancer: the role of insulin and insulin-like growth factor-I

  2001cited by this paper
• Leptin is associated with increased prostate cancer risk: a nested case-referent study.

  2001cited by this paper
• Leptin concentrations in the United States: relations with demographic and anthropometric measures.

  2001cited by this paper
• Leptin in relation to prostate cancer and benign prostatic hyperplasia.

  1998cited by this paper
• C-peptide measurement: methods and clinical utility.

  1984cited by this paper

• Role of Metabolism and Metabolic Pathways in Prostate Cancer

  2023cites this paper
• Biomarkers of glucose homeostasis and inflammation with risk of prostate cancer: A case-cohort study.

  2022cites this paper
• EliScholar – A Digital Platform for Scholarly Publishing at Yale

  2021cites this paper
• Could Reducing Body Fatness Reduce the Risk of Aggressive Prostate Cancer via the Insulin Signalling Pathway? A Systematic Review of the Mechanistic Pathway

  2021cites this paper
• Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs

  2021cites this paper
• Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate Cancer.

  2021cites this paper
• Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis

  2020cites this paper
• Leptin Level Variance in Adults With and Without Cancer

  2019cites this paper
• Absence of excess body fatness

  2019cites this paper
• Appetite-regulating hormones—leptin, adiponectin and ghrelin—and the development of prostate cancer: a systematic review and exploratory meta-analysis

  2019cites this paper
• Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease

  2018cites this paper
• Serum C-peptide concentration and prostate cancer

  2018influential citation
• Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer

  2018cites this paper
• Cross-Sectional Epidemiology and Intervention Studies of Mediators of the Energy Imbalance-Prostate Cancer Association

  2018cites this paper
• Molecular Mechanisms of Advanced Prostate Cancer

  2018cites this paper
• Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer

  2017cites this paper
• The association between plasma C-peptide concentration and the risk of prostate cancer: a nested case–control study within a Japanese population-based prospective study

  2017cites this paper
• Association between Manganese Superoxide Dismutase (MnSOD) Polymorphism and Prostate Cancer Susceptibility: A Meta-Analysis

  2016cites this paper
• MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility.

  2016cites this paper
• Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.

  2016cites this paper
• Association between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysis

  2016cites this paper
• Glucose Metabolism in High-Risk Prostate Cancer Patients throughout the Acute Disease Trajectory

  2016cites this paper
• Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart Study

  2016influential citation
• Diabetes and mortality in patients with prostate cancer: a meta-analysis

  2016cites this paper
• Obesity and Prostate Cancer.

  2016cites this paper
• Serum concentrations of adipokines in men with prostate cancer and benign prostate hyperplasia.

  2015cites this paper
• Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.

  2015cites this paper
• Prediagnostic plasma IGFBP‐1, IGF‐1 and risk of prostate cancer

  2015cites this paper
• Metabolic syndrome‐like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

  2015cites this paper
• Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: A meta-analysis.

  2014cites this paper